NEWANJAk - FACEIT level 10, 2,309 ELO

Serbia
On FACEIT since 2014 102 matches tracked 68 matches in 30 days
ELO ▼ 136
2,309
30-day peak: 2,486
Rank EU
#103,486
Serbia #1,095 in Serbia
Last updated:

NEWANJAk at a glance

Level 10 2,309 ELO best map Mirage (58%)
2,250-2,499 ELO

Last 20 matches compared with 2,996 players in this group: K/R, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 31%
0.98
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.37 ConsistencyShare of matches with a rating of 0.90 or higher. 45%
K/R
0.71
better than 34% of players
2,250-2,499 ELO avg: 0.74
Last 12 months
ADR
78.2
better than 36% of players
2,250-2,499 ELO avg: 80.9
Last 12 months
Win rate
45%
better than 28% of players
2,250-2,499 ELO avg: 51%
Last 12 months

Facts

177 ELO Next goal ELO to the peak (2,486)
9 Comebacks last 90 days
8 W · 10 L Overtime in overtime
Mirage Favorite map 38 of 102 matches
Mirage 58% Map pool tip weakest: Anubis 50%
4 knife kills Rare kills last 90 days
22:00-0:00 Playing times On Sundays
18:00-24:00 Best time 58% win rate vs. 53%
FormMapsTiming

177 ELO away from the recorded peak (2,486). 9 wins after trailing at halftime (last 90 days). 18 matches in overtime, 8 of them won (last 90 days). Most played: Mirage (38 of 102 matches). Strongest map: Mirage (58% win rate, 38 matches). Weakest: Anubis (50%, 14 matches). 4 knife kills (last 90 days). Plays most on Sundays between 22:00 and 0:00 (based on 102 matches). Best results between 18:00 and 24:00: 58% win rate vs. 53% overall (77 matches).

About NEWANJAk

NEWANJAk plays CS2 on FACEIT level 10 with 2,309 ELO. The stats cover 102 matches. NEWANJAk plays Mirage the most and wins it the most: 58% win rate in 38 matches. NEWANJAk won 9 matches after trailing at halftime (last 90 days). Last 20 matches: 9 wins, 11 losses, -4 ELO. NEWANJAk does best between 18:00 and 24:00: 58% win rate in 77 matches.